Lauren M. Sabella
Net Worth
Last updated:
What is Lauren M. Sabella net worth?
The estimated net worth of Ms. Lauren M. Sabella is at least $13,590,754 as of 2 Dec 2019. She has earned $2,211,604 from insider trading and has received compensation worth at least $11,379,150 in Acorda Therapeutics, Inc..
What is the salary of Lauren M. Sabella?
Ms. Lauren M. Sabella salary is $758,610 per year as Chief Operating Officer in Acorda Therapeutics, Inc..
How old is Lauren M. Sabella?
Ms. Lauren M. Sabella is 64 years old, born in 1961.
What stocks does Lauren M. Sabella currently own?
As insider, Ms. Lauren M. Sabella owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Acorda Therapeutics, Inc. (ACOR) | Chief Operating Officer | 12,624 | $0 | $0 |
What does Acorda Therapeutics, Inc. do?
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
Lauren M. Sabella insider trading
Acorda Therapeutics, Inc.
Ms. Lauren M. Sabella has made 18 insider trades between 2010-2019, according to the Form 4 filled with the SEC. Most recently she sold 1,513 units of ACOR stock worth $2,421 on 2 Dec 2019.
The largest trade she's ever made was exercising 24,375 units of ACOR stock on 8 Jun 2018. As of 2 Dec 2019 she still owns at least 12,624 units of ACOR stock.
Acorda Therapeutics key executives
Acorda Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Burkhard Blank M.D. (70) Consultant
- Dr. Ron Cohen M.D. (69) Founder, Chief Executive Officer, Pres & Director
- Ms. Lauren M. Sabella (64) Chief Operating Officer